Primary immunodeficiencies associated with pneumococcal disease.
about
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyWhole-exome-sequencing-based discovery of human FADD deficiencyRecombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal diseaseSevere infectious diseases of childhood as monogenic inborn errors of immunityMechanisms of Bacterial Colonization of the Respiratory TractPneumococcal vaccine and patients with pulmonary diseasesPneumococcal Capsules and Their Types: Past, Present, and FuturePrevention of infections during primary immunodeficiencyHumoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infectionCirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniaeThe role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model.Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.Invasive pneumococcal disease in children can reveal a primary immunodeficiency.Inherited disorders of human Toll-like receptor signaling: immunological implications.A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.Human genetics of infectious diseases: a unified theoryA novel mutation in the complement component 3 gene in a patient with selective IgA deficiency.Immunity to microbes: lessons from primary immunodeficiencies.Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management.Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors.The role of the macrophage in lung disease mediated by bacteria.Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.The battle with the host over microbial size.The history of pneumococcal conjugate vaccine development: dose selection.A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signalingLocation in the spleen dictates the function of murine neutrophils.Macrophage migration inhibitory factor promotes clearance of pneumococcal colonizationRisk factors for community-acquired bacterial meningitis.Increased chain length promotes pneumococcal adherence and colonization.Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection.IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies.Can your genes make you more prone to pneumococcal disease?Update on the management of the immunodeficiency in ataxia-telangiectasia.Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes.
P2860
Q24301912-7494372C-71EA-4F38-908D-95D9325DD378Q24309135-0D99256D-B2D5-4623-8345-2CB37943E769Q24678809-DD72D969-77F0-44A3-9EF4-6C2C4AB9C50DQ26775891-1A4E6129-67CD-49EA-8F87-F7BB5D7B8C05Q26778724-49F526B1-23C7-4BDC-AE6E-F9144791BEBCQ26825944-A0EB05E3-560B-4605-9387-4085C44D0722Q27006887-4B6A8C54-474C-4AC7-9D16-A481D566D13DQ27008430-64DDE0C0-E4BA-4E9D-83AD-04DC294A862BQ27023322-8F59C81E-E760-4F79-A405-997A76B9C1DDQ33303634-58818B03-71F7-4351-B970-57257C277A75Q33606856-6C0665F5-B156-47E3-88D6-B64A08A09ADFQ33675787-346DD620-0B23-43B7-B6FB-FAC6B8C2A08EQ33917973-93C832D8-6425-4082-8D80-69909EDD62CCQ34386299-4B4C8CC7-2C42-417D-9DBD-3D080A7F74EFQ34795980-F07F2E21-8448-4D0F-BA60-1F6C70008913Q35012945-13914A0D-E5BF-4BE5-BD4A-EF2FD55949C2Q35036583-7E299329-376A-40C5-8E1C-9ECC64DCCE69Q35122775-4F9062C0-778D-4928-B51F-A8A4533C6006Q35147583-D6159D58-2980-47D6-820E-0A3668540509Q35752931-4CB29F11-EE73-40BA-A8ED-030A7CD0E09BQ36563047-1E807555-D77A-42B0-B422-6D7EF2E8ECE8Q36729350-CF448C0C-5531-4700-9029-E0C8385B72E2Q36799619-FC1F4CEB-1099-49E2-84A7-CA8F92BE0EE3Q36839862-923BA40C-D96E-46F8-AEAC-269CC1D0949DQ37030655-AA85A9E6-B29A-467F-B8D0-0066ABA41233Q37069112-961422CC-8E6D-421C-BC6D-075F47EB2E0BQ38080323-CB5455D5-2E4F-46E8-98BF-620A96481861Q38160248-B854DC3C-91A9-4289-899C-4515A568F1BEQ38220556-0DBB6F54-AECB-43F9-97BB-0428E5FB574AQ38375236-0C17ED79-7D9A-44A3-88A1-053449599858Q38829708-49FFFFE6-E01E-4B88-9394-0F9BB4996751Q38984814-A60699CA-4CCB-4484-830C-9CCCF11F0EDAQ39182388-BC02DEF2-F759-4C8F-B4CC-BB3FBC415C01Q39309422-F11F9CB4-46E9-4A19-8247-6FD8312FA344Q40381150-25F0E8EA-61A5-4C51-9F96-F0BB15DB5C64Q41112798-5BCD3B83-06E0-4DF6-B365-1019142FB992Q41989467-C153066B-6A24-46B0-9D86-73BE129AF08CQ42917023-8F326CD3-7548-4069-8814-853DF776D084Q43061574-FEB58334-0DE4-44D4-BD54-4C97774FC0A3Q43894530-D62068E8-BEAE-4DE9-8A59-406F63798C97
P2860
Primary immunodeficiencies associated with pneumococcal disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Primary immunodeficiencies associated with pneumococcal disease.
@ast
Primary immunodeficiencies associated with pneumococcal disease.
@en
type
label
Primary immunodeficiencies associated with pneumococcal disease.
@ast
Primary immunodeficiencies associated with pneumococcal disease.
@en
prefLabel
Primary immunodeficiencies associated with pneumococcal disease.
@ast
Primary immunodeficiencies associated with pneumococcal disease.
@en
P50
P1476
Primary immunodeficiencies associated with pneumococcal disease.
@en
P2093
Cheng-Lung Ku
P304
P356
10.1097/00130832-200312000-00006
P577
2003-12-01T00:00:00Z